Tag: merit medical
Merit Medical announces US FDA approval of the Wrapsody cell-impermeable endoprosthesis
Merit Medical Systems announced today that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this...
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from the single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access...
Vascular News’ top 10 most popular stories of September 2024
Six-month data from Merit Medical's Wrapsody WAVE trial, an update on the NHS England Acute Aortic Dissection Toolkit, and a large meta-analysis of endovascular...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody arteriovenous access efficacy (WAVE) pivotal trial....
Merit Medical expands SwiftNinja steerable microcatheter offering
Merit Medical has announced the expansion of itsSwiftNinja steerable microcatheter product line. New sizes include a low-profile 2.4Fr distal diameter option in 125-cm and...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
First-in-human study of Wrapsody cell-impermeable endoprosthesis yields “very promising” results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
Merit Medical’s Wrapsody System receives CE mark
Merit Medical has received CE mark approval for the Wrapsody endovascular stent graft system from the British Standards Institution. The Wrapsody system is a...
Merit Medical’s EmboCube embolisation gelatin and Torpedo gelatin foam indicated for...
Merit Medical Systems has announced that both its EmboCube (syringe-loaded embolisation gelatin foam) and Torpedo (uniform, preshaped gelatin foam loaded into a cartridge with...
Merit Medical receives FDA breakthrough device designation for WRAPSODY endovascular stent...
Merit Medical Systems recently announced that it has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for the Merit...
PreludeSYNC DISTAL compression device now available globally
The PreludeSYNC DISTAL compression device (Merit Medical) is now available in US, European, Middle Eastern, African, and Asia-Pacific markets. The device is the first...
Merit Medical acquires assets of Vascular Insights
Merit Medical Systems, Inc. has announced that it has acquired substantially all of the assets of Vascular Insights, LLC, based in Quincy, USA. Vascular...
Merit Medical named exclusive distributor of Q50 Plus
Merit Medical Systems has been named the exclusive global distributor of the Q50 Plus Stent Graft Balloon Catheter (QXMédical). The Q50 Plus is used...
First patients enrolled in Bluegrass Vascular post-market SAVE study
Bluegrass Vascular Technologies has enrolled over one third of its patients in the company's post-market SAVE (Surfacer System to Facilitate Access in Venous Occlusions)...
Bluegrass Vascular announces strategic relationship with Merit Medical
Bluegrass Vascular Technologies is entering into a strategic relationship with Merit Medical Systems. The agreement will streamline European distribution of the recently CE mark-approved Surfacer Inside-Out...
Merit Medical receives 510(k) clearance for the SwiftNINJA steerable microcatheter
Merit Medical Systems has received 510(k) clearance for the SwiftNINJA steerable microcatheter, covering peripheral and coronary applications. With the exception of Japan, Merit has...
Merit Medical launches Super HeRO and HeRO Ally products
Merit Medical Systems has announced the launch of the proprietary Super HeRO and HeRO Ally products, additions to Merit’s expanding portfolio of dialysis access...
